Skip to main content
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.970
-0.010 (-1.02%)
At close: Feb 27, 2026, 4:00 PM EST
0.950
-0.020 (-2.06%)
After-hours: Feb 27, 2026, 7:13 PM EST

RedHill Biopharma Revenue

RedHill Biopharma had revenue of $4.08M in the half year ending June 30, 2025, a decrease of -24.39%. This brings the company's revenue in the last twelve months to $9.55M, up 157.62% year-over-year. In the year 2024, RedHill Biopharma had annual revenue of $8.04M with 23.17% growth.

Revenue (ttm)
$9.55M
Revenue Growth
+157.62%
P/S Ratio
0.52
Revenue / Employee
$272,857
Employees
35
Market Cap
4.96M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.04M1.51M23.17%
Dec 31, 20236.53M-55.27M-89.43%
Dec 31, 202261.80M-23.96M-27.94%
Dec 31, 202185.76M21.40M33.25%
Dec 31, 202064.36M58.07M923.03%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IM Cannabis 37.61M
Sunshine Biopharma 37.32M
Biofrontera 37.16M
cbdMD 19.09M
Sonoma Pharmaceuticals 17.72M
InMed Pharmaceuticals 4.51M
China Pharma Holdings 4.05M
China SXT Pharmaceuticals 1.54M
Revenue Rankings

RDHL News

More News